A new civil case, Do v. Singh et al (Case Number: 3:26-cv-02656), has been filed in the U.S. District Court for the Northern District of California. The filing includes a Verified Shareholder Derivative Complaint against Ann M. Cunningham, Joanne Curley, Paul Edick, Margaret M. Fitzpatrick, Jerry B. Gin, Joshua Prince, Mary L. Rotunno, Jon S. Saxe, Shawn K. Singh, and Vistagen Therapeutics, Inc. The basis of the suit is Federal Question, with the Nature of Suit identified as Stockholders Suits.

This filing initiates legal proceedings that could impact corporate governance and shareholder rights at Vistagen Therapeutics, Inc. Compliance officers and legal professionals should monitor this case for potential implications related to director liability, shareholder derivative actions, and securities law compliance. No specific compliance deadlines or penalties are detailed in this initial filing, but the nature of the suit suggests potential for significant legal scrutiny and possible remedies if the allegations are proven.